Vaccinating children is considered crucial for herd immunity. Moderna’s two-dose vaccine is already authorized for adults aged 18 years and above and now the company has said that a clinical study of its COVID-19 vaccine, mRNA-1273, has shown 100 per cent effectiveness in the 12 to 17 years age group. In this week’s Beyond Just Money, we discuss vaccination among children and how it is being planned out.